Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, High grade lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 1
This study is looking at a type of CAR T-cell therapy called AUTO1 (also called obe-cel) for children and teenagers with B cell or B cell .
It is open to children and teenagers with a B cell cancer that has come back or the treatment has stopped working.
We use the term ‘you’ in this summary, but if you are a parent we are referring to your child.
At the moment the team are not recruiting children and teenagers with B cell acute lymphocytic leukaemia.
Recruitment start: 31 October 2023
Recruitment end: 31 March 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Ghorashian
Autolus Limited
Last reviewed: 08 Jan 2026
CRUK internal database number: 20022
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
